Research map: Etiology and Management of Venous Thromboembolism (VTE) Recurrence in Patients Anticoagulated for VTE: A Single-Center Study

Back to the article

Papers in this map

  1. Oral Rivaroxaban for Symptomatic Venous Thromboembolism · The EINSTEIN Investigators · 2010 · 3275 citations · Cited by this paper
  2. Multigene panel analysis of connective tissue and vascular genes in patients with a bleeding disorder of unknown cause or a cerebrovascular event · 2026 · Related
  3. Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism · The EINSTEIN–PE Investigators · 2012 · 2373 citations · Cited by this paper
  4. Call to action: identifying an underlying bleeding disorder in adolescents with heavy menstrual bleeding · 2026 · Related
  5. Oral Apixaban for the Treatment of Acute Venous Thromboembolism · Giancarlo Agnelli · 2013 · 2335 citations · Cited by this paper
  6. EP1T3_7 Impact of a Regional Plasma-PBM Strategy on Clinical Consumption and Economic Optimization of the Toll Manufacturing Model: A 10-Year Analysis (2016-2025) · 2026 · Related
  7. Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism · Gary E. Raskob · 2017 · 1633 citations · Cited by this paper
  8. EP3T3_2 Implementation of a hospital-wide pathway for patients refusing blood components: early experience from a tertiary centre · 2026 · Related
  9. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update · Nigel S. Key · 2019 · 1518 citations · Cited by this paper
  10. EP2T7_1 Early use of Tranexamic Acid in postpartum hemorrhage · 2026 · Related
  11. Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer · Giancarlo Agnelli · 2020 · 1067 citations · Cited by this paper
  12. EP1T7_6 Clinical Impact of Multimodal Patient Blood Management in Urgent Cardiac Surgery for Infective Endocarditis: A Retrospective Cohort Study · 2026 · Related
  13. A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome · Mark Andrew Crowther · 2003 · 920 citations · Cited by this paper
  14. Venous Thromboembolism in China: Epidemiology, Management Strategies, and Future Directions · 2026 · Related
  15. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome · Vittorio Pengo · 2018 · 824 citations · Cited by this paper
  16. Disseminated Intravascular Coagulation in Chimeric Antigen Receptor T-Cell Therapy: A Six-Year Nationwide Analysis of Clinical Outcomes and Healthcare Resource Utilization in Patients with Hematologic Malignancies · 2026 · Related
  17. Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges · Ashley Chen · 2020 · 673 citations · Cited by this paper
  18. Evaluation and application of automated quality control in clinical coagulation testing · 2026 · Related
  19. Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial · Robert D. McBane · 2019 · 594 citations · Cited by this paper
  20. EP1T4_7 Prothrombotic phenotype after severe trauma in ICU patients: serial ROTEM reveals a shift over 72 hours · 2026 · Related
  21. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 · Dominique Farge · 2022 · 480 citations · Cited by this paper
  22. Cancer-associated venous thromboembolism · Alok A. Khorana · 2022 · 476 citations · Cited by this paper
  23. Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review · Wonkyung Byon · 2019 · 353 citations · Cited by this paper
  24. Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome · Josep Ordi‐Ros · 2019 · 324 citations · Cited by this paper
  25. Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation · Aya Fukuma Ozaki · 2020 · 260 citations · Cited by this paper
  26. Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation · Karlyn A. Martin · 2021 · 250 citations · Cited by this paper
  27. Acute Pulmonary Embolism in a National Danish Cohort: Increasing Incidence and Decreasing Mortality · Per Lehnert · 2018 · 177 citations · Cited by this paper
  28. Pulmonary Embolism · Susan Rebecca Kahn · 2022 · 156 citations · Cited by this paper
  29. May‐Thurner syndrome: History of understanding and need for defining population prevalence · Michelle M. Harbin · 2019 · 150 citations · Cited by this paper
  30. Select Drug-Drug Interactions With Direct Oral Anticoagulants · Barbara S. Wiggins · 2020 · 144 citations · Cited by this paper
  31. Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance · Karlyn A. Martin · 2017 · 135 citations · Cited by this paper
  32. Treatment of cancer‐associated venous thromboembolism: 12‐month outcomes of the placebo versus rivaroxaban randomization of the SELECT‐D Trial (SELECT‐D: 12m) · Andrea Marshall · 2020 · 86 citations · Cited by this paper
  33. Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer · Giancarlo Agnelli · 2021 · 57 citations · Cited by this paper
  34. Monoclonal gammopathy of thrombotic/thrombocytopenic significance · Adam J. Kanack · 2023 · 49 citations · Cited by this paper
  35. Dosage of Anticoagulants in Obesity: Recommendations Based on a Systematic Review · Anders Mønsted Abildgaard · 2020 · 48 citations · Cited by this paper
  36. Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism · Dalene M. Bott‐Kitslaar · 2019 · 45 citations · Cited by this paper
  37. Long‐Term Medication Adherence Trajectories to Direct Oral Anticoagulants and Clinical Outcomes in Patients With Atrial Fibrillation · Jaejin An · 2021 · 44 citations · Cited by this paper
  38. Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients – 30 months follow‐up · Trine‐Lise Larsen · 2022 · 44 citations · Cited by this paper
  39. Direct oral anticoagulants after bariatric surgery—What is the evidence? · Russell Leong · 2022 · 41 citations · Cited by this paper

Source: OpenAlex (CC0)